Current state of medication treatment practice for heart failure with reduced ejection fraction among cardiologists in Japan: a survey on the relationship between satisfaction levels and adherence to guideline-directed medical therapy

Approximately 50% of the respondents were dissatisfied with the current pharmacological treatment of patients with chronic HFrEF, suggesting that SGLT2 inhibitors were prescribed less frequently and that patient management tended to be guided more by individual symptoms and underlying HF characteristics rather than strict adherence to GDMT. The use of SGLT2 inhibitors was significantly associated with higher treatment satisfaction, particularly among physicians who adhered more closely to current GDMT recommendations.